Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 47-59

  Beato, Miguel ^b   Candau, Reyes ^a   Chávez, Sebastián ^b   Möws, Christian ^b   Truss, Mathias ^b  

^a WISTAR INSTITUTE   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGENOUS COMPOUND; HORMONE RECEPTOR; TRANSCRIPTION FACTOR;

CHROMATIN; CONFERENCE PAPER; CYTOCHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; NUCLEOSOME; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

EID: 0029921517     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00223-5     Document Type: Conference Paper

References (144)

1. Nathan D. F. and Lindquist S.: Mutational analysis of hsp90 function: interactions with a steroid receptor and a protein kinase. Molec. Cell. Biol. 15 (1995) 3917-3925.
2. Kimura Y., Yahara I. and Lindquist S.: Role of the protein chaperone YDJ1 in establishing hsp90-mediated signal transduction pathways. Science 268 (1995) 1362-1365.
3. Willmann T. and Beato M.: Steroid-free glucocorticoid receptor binds specifically to mouse mammar mammary tumour virus DNA. Nature 324 (1986) 688-691.
4. Delabre K., Guiochon-Mantel A. and Milgrom E.: In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 4421-4425.
5. Becker P. B., Gloss B., Schmid W., Strähle U. and Schütz G.: In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature 324 (1986) 686-688.
6. Truss M., Bartsch J. and Beato M.: Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 11,333-11,337.
7. Schauer M., Chalepakis G., Willmann T. and Beato M: Binding of hormone accelerates the kinetics of glucocorticoid and progesterone receptor binding to DNA. Proc. Natn. Acad. Sci. U.S.A. 86 (1989) 1123-1127.
8. Herrlich P. and Ponta H.: Mutual cross-modulation of steroid-retinoic acid receptor and AP-1 transcription factor activities. A novel property with practical implications. Trends Endocr. Metab. 5 (1994) 341-346.
9. Schüle R., Müller M., Otsuka-Murakami H. and Renkawitz R.: Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature 332 (1988) 87-90.
10. Schüle R., Müller M., Otsuka-Murakami H. and Renkawitz R.: Many transcription factors interact synergistically with steroid receptors. Science 242 (1988) 1418-1420.
11. Strähle U., Schmid W. and Schütz G.: Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J. 7 (1988) 3389-3395.
12. Ankenbauer W., Strähle U. and Schütz G.: Synergistic action of glucocorticoid and estradiol responsive elements. Proc. Natn. Acad. Sci. U.S.A. 85 (1988) 7526-7530.
13. Schmid W., Strähle U., Schütz G., Schmitt J. and Stunnenberg H.: Glucocorticoid receptor binds cooperatively to adjacent recognition sites. EMBO J. 8 (1989) 2257-2263.
14. Toohey M. G., Lee J. W., Huang M. and Peterson D. O.: Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus. J. Virol. 64 (1990) 4477-4488.
15. Nowock J., Borgmeyer U., PÅschel A., Rupp A. W. and Sippel A. E.: The TGGCA protein binds to the MMTV-LTR, the adenovirus origin of replication, and BK virus. Nucl. Acid Res. 13 (1985) 2045-2062.
16. Miksicek R., Borgmeyer U. and Nowock J.: Interaction of the TGGCA-binding protein with upstream sequences is required for efficient transcription of mouse mammary tumor virus. EMBO J. 6 (1987) 1355-1360.
17. Buetti E. and Kühnel B.: Distinct sequence elements involved in the glucocorticoid regulation of the mouse mammary tumor virus promoter identified by linker scanner mutagenesis. J. Molec. Biol. 190 (1986) 379-390.
18. Brüggemeier U., Rogge L., Winnacker E. L. and Beato M.: Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding. EMBO J. 9 (1990) 2233-2239.
19. Kalff M., Gross B. and Beato M.: Progesterone receptor stimulates transcription of mouse mammary tumour virus in a cell-free system. Nature 344 (1990) 360-362.
20. Möws C., Preiss T., Slater E. P., Cao X., Verrijzer C. P., van der Vliet P. and Beato M.: Two independent pathways for transcription from the MMTV promoter. J. Steroid Biochem. Molec. Biol. 51 (1994) 21-32.
21. Brüggemeier U., Kalff M., Franke S., Scheidereit C. and Beato M.: Ubiquitous transcription factor OTF-1 mediates induction of the mouse mammary tumour virus promoter through synergistic interaction with hormone receptors. Cell 64 (1991) 565-572.
22. Huang M., Lee J. W. and Peterson D. O.: Functional redundancy of octamer elements in the mouse mammary tumor virus promoter. Nucleic Acids Res. 21 (1993) 5235-5241.
23. Buetti E.: Stably integrated mouse mammary tumor virus long terminal repeat DNA requires the octamer motifs for basal promoter activity. Molec. Cell. Biol. 14 (1994) 1191-1203.
24. Wieland S., Döbbeling U. and Rusconi S.: Interference and synergism of glucocorticoid receptor and octamer factors. EMBO J. 10 (1991) 2513-2522.
25. Gouillet F., Sola B., Couette B. and Richard-Foy H.: Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucl. Acids Res. 19 (1991) 1563-1569.
26. Cavin C. and Buetti E.: Tissue-specific and ubiquitous factors binding next to the glucocorticoid receptor modulate transcription from the mouse mammary tumor virus promoter. J. Virol. 69 (1995) 3759-3770.
27. Ross S. R. and Sloter D.: Glucocorticoid regulation of mouse mammary tumor virus sequences in transgenic mice. Proc. Natn. Acad. Sci. U.S.A. 82 (1985) 5880-5884.
28. Rollini P., Billotte J., Kolb E. and Diggelmann H.: Expression pattern of mouse mammary tumor virus in transgenic mice carrying exogenous proviruses of different origins. J. Virol. 66 (1992) 4580-4586.
29. Mok E., Golovkina T. V. and Ross S. R.: A mouse mammary tumor virus mammary gland enhancer confers tissue-specific but not lactation-dependent expression in transgenic mice. J. Virol. 66 (1992) 7529-7532.
30. Hagen G., Muller S., Beato M. and Suske G.: Cloning by recognition site screening of 2 novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res. 20 (1992) 5519-5525.
31. Roux J., Pictet R. and Grange T.: Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol. 14 (1995) 385-396.
32. Miner J. N. and Yamamoto K. R.: Regulatory crosstalk at composite response elements. Trends Biochem. Sci. 16 (1991) 423-426.
33. Mordacq J. C. and Linzer D. I. H.: Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression. Genes Dev. 3 (1989) 760-769.
34. Diamond M. I., Miner J. N., Yoshinaga S. K. and Yamamoto K. R.: Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 (1990) 1266-1272.
35. Miner J. N. and Yamamoto K. R.: The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev. 6 (1992) 2491-2501.
36. Pearce D. and Yamamoto K. R.: Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259 (1993) 1161-1165.
37. Yoshinaga S. K. and Yamamoto K. R.: Signaling and regulation by a mammalian glucocorticoid receptor in Drosophila cells. Mol. Endocr. 5 (1991) 844-853.
38. Vardimon L., Fox L. L., Degenstein L. and Moscona A. A.: Cell contacts are required for induction by cortisol of glutamine synthetase gene transcription in the retina. Proc. Natn. Acad. Sci. U.S.A. 85 (1988) 5981-5985.
39. Zhang H. and Young A. P.: A single upstream glucocorticoid response element justaposed to an AP1/ATF/CRE-like site renders the chicken glutamine synthetase gene hormonally inducible in transfected retina. J. Biol. Chem. 266 (1991) 24,332-24,338.
40. Bendror I., Havazelet N. and Vardimon L.: Developmental control of glucocorticoid receptor transcriptional activity in embryonic retina. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 1117-1121.
41. Benor S. and Okret S.: Involvement of a C/EBP-like protein in the acquisition of responsiveness to glucocorticoid hormones during chick neural retina development. Molec. Cell. Biol. 13 (1993) 331-340.
42. Berko-Flint Y., Levkowitz G. and Vardimon L.: Involvement of c-Jun in the control of glucocorticoid receptor transcriptional activity during development of chicken retinal tissue. EMBO J. 13 (1994) 646-654.
43. Reisfeld S. and Vardimon L.: Cell to cell contacts control the transcription activity of the glucocorticoid receptor. Molec. Endocr. 8 (1994) 1224-1233.
44. Schüle R. and Evans R. M.: Cross-coupling of signal transduction pathways - zinc finger meets leucine zipper. Trends Genet. 7 (1991) 377-381.
45. Schüle R., Rangarajan P., Kliewer S., Ransone L. J., Bolado J., Yang N., Verma I. M. and Evans R. M.: Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62 (1990) 1217-1226.
46. Jonat C., Rahmsdorf H., Park K., Cato A., Gebel S., Ponta H. and Herrlich P.: Antitumor promotion and antiinflamation: down-regulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62 (1990) 1189-1204.
47. König H., Ponta H., Rahmsdorf H. J. and Herrlich P.: Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11 (1992) 2241-2246.
48. Lucibello F. C., Slater E. P., Joos K. U., Beato M. and Müller R.: Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J. 9 (1990) 2827-2834.
49. Yang-Yen H.-F., Chambard J.-C., Sun Y.-L., Smeal T., Schmidt T. J., Drouin J. and Karin M.: Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62 (1990) 1205-1215.
50. Shemshedini L., Knauthe R., Sassone-Corsi P., Pornon A. and Gronemeyer H.: Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J. 10 (1991) 3839-3849.
51. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H. J., Herrlich P. and Cato A. C. B.: A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13 (1994) 4087-4095.
52. Helmberg A., Auphan N., Caelles C. and Karin M.: Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14 (1995) 452-460.
53. Liu W., Hillmann A. G. and Harmon J. M.: Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors. Molec. Cell. Biol. 15 (1995) 1005-1013.
54. Webb P., Lopez G. N., Uht R. M. and Kushner P. J.: Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Molec. Endocr. 9 (1995) 443-456.
55. Gauthier J. M., Bourachot B., Doucas V., Yaniv M. and Moreau-Gachelin F.: Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J. 12 (1993) 5089-5096.
56. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T. and Matsushima K.: Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-κB is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269 (1994) 13,289-13,295.
57. Ray A. and Prefontaine K. E.: Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 752-756.
58. Ray A., Siegel M. D., Prefontaine K. E. and Ray P.: Antiinflammation: direct physical association and functional antagonism between transcription factor NF-κB and the glucocorticoid receptor. Chest 107 (1995) S139.
59. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J. A. and Van der Saag P. T.: Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Molec. Endocr. 9 (1995) 401-412.
60. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A. and Baldwin A. S.: Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Molec. Cell. Biol. 15 (1995) 943-953.
61. Chang T. J., Scher B. M, Waxman S. and Scher W.: Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Molec. Endocr. 7 (1993) 528-542.
62. Burns K., Duggan B., Atkinson E. A., Famulski K. S., Nemer M., Bleackley R. C. and Michalak M.: Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367 (1994) 476-480.
63. Dedhar S., Rennie P. S., Shago M., Hagesteijn C. Y. L., Yang H. L., Filmus J., Hawley R. G., Bruchovsky N., Cheng H., Matusik R. J. and Giguere V.: Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367 (1994) 480-483.
64. Dedhar S.: Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem. Sci. 19 (1994) 269-271.
65. Pierce J., Fee B. E., Toohey M. G. and Peterson D. O.: A mouse mammary tumor virus promoter element near the transcription initiation site. J. Virol. 67 (1993) 415-424.
66. Schatt M. D., Rusconi S. and Schaffner W.: A single DNA-binding transcription factor is sufficient for activation from a distant enhancer and/or from a promoter position. EMBO J. 9 (1990) 481-487.
67. Sadovsky Y., Webb P., Lopez G., Baxter J. D., Fitzpatrick P. M., Gizang-Ginsberg E., Cavailles V., Parker M. G. and Kushner P. J.: Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Molec. Cell. Biol. 15 (1995) 1554-1563.
68. Brou C., Wu J., Ali S., Scheer E., Lang C., Davidson I., Chambon P. and Tora L.: Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res. 21 (1993) 5-12.
69. Brou C., Chaudhary S., Davidson I., Lutz Y., Wu J., Egly J. M., Tora L. and Chambon P.: Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J. 12 (1993) 489-499.
70. Jacq X., Brou C., Lutz Y., Davidson I., Chambon P. and Tora L. : Human TAFI30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79 (1994) 107-117.
71. Ha I., Roberts S., Maldonado E., Sun X. Q., Kim L. U., Green M. and Reinberg D.: Multiple functional domains of human transcription factor-IIB: distinct interactions with 2 general transcription factors and RNA polymerase-II. Genes Dev. 7 (1993) 1021-1032.
72. Roberts S. G. E., Ha I., Maldonado E., Reinberg D. and Green M. R.: Interaction between an acidic activator and transcription factor-TFIIB is required for transcriptional activation. Nature 363 (1993) 741-744.
73. Tsai S. Y., Sagami I., Wang H., Tsai M. and O'Malley B. W.: Interactions between a DNA-binding transcription factor (COUP) and non-DNA binding factor (S300-II). Cell 50 (1987) 701-709.
74. Ing N. H., Beekman J. M., Tsai S. Y., Tsai M. J. and O'Malley B. W.: Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267 (1992) 17,617-17,623.
75. Baniahmad A., Ha I., Reinberg D., Tsai S., Tsai M. J. and O'Malley B. W.: Interaction of human thyroid hormone receptor-β with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 8832-8836.
76. MacDonald P. N., Sherman D. R., Dowd D. R., Jefcoat S. C. and DeLisle R. K.: The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem. 270 (1995) 4748-4752.
77. Blanco J. C., Wang I. M., Tsai S. Y., Tsai M. J., O'Malley B. W., Jurutka P. W., Haussler M. R. and Ozato K.: Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natn. Acad. Sci. U.S.A. 92 (1995) 1535-1539.
78. Malik S. and Karathanasis S.: Transcriptional activation by the orphan nuclear receptor ARP-1. Nucleic Acids Res. 23 (1995) 1536-1543.
79. Hadzic E., Desaiyajnik V., Helmer E., Guo S., Wu S. J., Koudinova N., Casanova J., Raaka B. M. and Samuels H. H.: A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Molec. Cell. Biol. 15 (1995) 4507-4517.
80. Meyer M. E., Quirinstricker C., Lerouge T., Bocquel M. T. and Gronemeyer H.: A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 267 (1992) 10,882-10,887.
81. 1 transactivation domain of the human glucocorticoid receptor with the basal transcriptional machinery. Molec. Cell. Biol. 13 (1993) 399-407.
82. Shemshedini L., Ji J. W., Brou C., Chambon P. and Gronemeyer H.: In vitro activity of the transcription activation functions of the progesterone receptor. Evidence for intermediary factors. J. Biol. Chem. 267 (1992) 1834-1839.
83. Kupfer S. R., Marschke K. B., Wilson E. M. and French F. S.: Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. J. Biol. Chem. 268 (1993) 17,519-17,527.
84. Landel C. C., Kushner P. J. and Greene G. L.: The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Molec. Endocr. 8 (1994) 1407-1419.
85. Cavaillès V., Dauvois S., Danielian P. S. and Parker M. G.: Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 10,009-10,013.
86. Halachmi S., Marden E., Martin G., Mackay H., Abbondanza C. and Brown M.: Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264 (1994) 1455-1458.
87. Danielian P. S., White R., Lees J. A. and Parker M. G.: Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11 (1992) 1025-1033.
88. Cavailles V., Dauvois S. L., Horset F., Lopez G., Hoare S., Kushner P. J. and Parker M. G.: Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14 (1995) 3741-3751.
89. Lee J. W., Choi H. S., Gyuris J., Brent R. and Moore D. D.: Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Molec. Endocr. 9 (1995) 243-254.
90. Kim Y. J., Bjorklund S., Li Y., Sayre M. H. and Kornberg R. D.: A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 77 (1994) 599-608.
91. Koleske A. J. and Young R. A.: An RNA polymerase-II holoenzyme responsive to activators. Nature 368 (1994) 466-469.
92. Lee J. W., Ryan F., Swaffield J. C., Johnston S. A. and Moore D. D.: Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374 (1995) 91-94.
93. LeDouarin B., Zechel C., Garnier J. M., Lutz Y., Tora L., Pierrat B., Heery D., Gronemeyer H., Chambon P. and Losson R.: The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14 (1995) 2020-2033.
94. Inoue S., Orimo A., Hosoi T., Kondo S., Toyoshima H., Kondo T., Ikegami A., Ouchi Y., Orimo H. and Muramatsu M.: Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 11,117-11,121.
95. Winston F. and Carlson M.: Yeast SNF/SWI transcriptional activators and the SPT/SIN chromatin connection. Trends Genet. 8 (1992) 387-391.
96. Yoshinaga S. K., Peterson C. L., Herskowitz I. and Yamamoto K. R.: Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258 (1992) 1598-1604.
97. Tamkun J. W., Deuring R., Scott M. P., Kissinger M., Pattatucci A. M., Kaufman T. C. and Kennison J. A.: brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68 (1992) 561-572.
98. Muchardt C. and Yaniv M.: A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila-brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12 (1993) 4279-4290.
99. Khavari P. A., Peterson C. L., Tamkun J. W., Mendel D. B. and Crabtree G. R.: BRG1 contains a conserved domain of the SW12/SNF2 family necessary for normal mitotic growth and transcription. Nature 366 (1993) 170-174.
100. Kwon H., Imbalzano A. N., Khavari P. A., Kingston R. E. and Green M. R.: Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature 370 (1994) 477-481.
101. Dunaief J. L., Strober B. E., Guha S., Khavari P. A., Alin K., Luban J., Begemann M., Crabtree G. R. and Goff S. P.: The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79 (1994) 119-130.
102. Almer A. and Hörz W.: Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast. EMBO J. 5 (1986) 2681-2687.
103. Almer A., Rudolph H., Hinnen A. and Hörz W.: Removal of positioned nucleosomes from the yeast PHO5 promoter upon induction releases additional upstream activating DNA elements. EMBO J. 5 (1986) 2689-2696.
104. Grunstein M.: Nucleosomes: regulators of transcription. T.I.G. 6 (1990) 395-400.
105. Elgin S. C.: Chromatin structure and gene activity. Curr. Opin. Cell Biol. 2 (1990) 437-45.
106. Beato M.: Transcriptional regulation of mouse mammary tumor virus by steroid hormones. Crit. Rev. Oncogen. 2 (1991) 195-210.
107. Perlmann T. and Wrange Ö.: Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7 (1988) 3073-3079.
108. Piña B., Truss M., Ohlenbusch H., Postma J. and Beato M.: DNA rotational positioning in a regulatory nucleosome is determined by base sequence. An algorithm to model the preferred superhelix. Nucleic Acids Res. 18 (1990) 6981-8987.
109. Archer T. K., Cordingley M. G., Wolford R. G. and Hager G. L.: Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Molec. Cell. Biol. 11 (1991) 688-698.
110. Richard-Foy H. and Hager G. L.: Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 6 (1987) 2321-2328.
111. Cordingley M. G., Riegel A. T. and Hager G. L.: Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell 48 (1987) 261-270.
112. Zaret K. S. and Yamamoto K. R.: Reversible and persistent changes in chromatin structure accompanying activation of a glucocorticoid-dependent enhancer element. Cell 38 (1984) 29-38.
113. Piña B., Barettino D. and Beato M.: Nucleosome positioning and regulated gene expression. In Oxford Surveys on Eukaryotic Genes. (Edited by N. Maclean). Oxford University Press, Oxford (1991) pp. 83-117.
114. Truss M., Bartsch J., Schelbert A., Haché R. J. G. and Beato M.: Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J. 14 (1995) 1737-1751.
115. Archer T. K., Lefebvre P., Wolford R. G. and Hager G. L.: Transcription factor loading on the MMTV promoter: A bimodal mechanism for promoter activation. Science 255 (1992) 1573-1576.
116. Cereghini S. and Yaniv M.: Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J. 3 (1984) 1243-1253.
117. Piña B., Haché R. J. G., Arnemann J., Chalepakis G., Slater E. P. and Beato M.: Hormonal induction of transfected genes depends on DNA topology. Molec. Cell. Biol. 10 (1990) 625-633.
118. Cordingley M. G. and Hager G. L.: Binding of multiple factors to the MMTV promoter in crude and fractionated nuclear extracts. Nucleic Acid Res. 16 (1988) 609-630.
119. Sadowski I., Ma J., Triezenberg S. and Ptashne M.: GAL4-VP16 is an unusually potent transcriptional activator. Nature 335 (1988) 563-564.
120. Chávez S., Candau R., Truss M. and Beato M.: Constitutive repression and NFI-dependent hormone activation of the MMTV promoter in yeast. Molec. Cell. Biol. 15 (1995) 6987-6998.
121. Kralli A., Bohen S. P. and Yamamoto K. R.: LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natn. Acad. Sci. U.S.A. 92 (1995) 4701-4705.
122. Garabedian M. J. and Yamamoto K. R.: Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Molec. Biol. Cell. 3 (1992) 1245-1257.
123. Burch J. B. E. and W. H.: Temporal order of chromatin structural changes associated with activation of the major chicken vitellogenin gene. Cell 33 (1983) 65-76.
124. Jost J. P., Seldran M. and Geiser M.: Preferential binding of estrogen-receptor complex to a region containing the estrogen-dependent hypomethylation site preceding the chicken vitellogenin II gene. Proc. Natn. Acad. Sci. U.S.A. 81 (1984) 429-433.
125. Wilks A. F., Cozens P. J., Mattaj I. W. and Jost J. P.: Estrogen induces a demethylation at the 5′ end region of the chicken vitellogenin gene. Proc. Natn. Acad. Sci. U.S.A. 79 (1982) 4252-4255.
126. Bruhat A. and Jost J. P.: In vivo estradiol-dependent dephosphorylation of the repressor MDBP-2-h1 correlates with the loss of in vitro preferential binding to methylated DNA. Proc. Natn. Acad. Sci. U.S.A. 92 (1995) 3678-3682.
127. Nitsch D., Stewart A. F., Boshart M., Mestril R., Weih F. and Schütz G.: Chromatin structure of the rat tyrosine aminotransferase gene relate to the function of its cis -acting elements. Molec. Cell. Biol. 10 (1990) 3334-3342.
128. Fritton H. P., Sippel A. E. and Igo-Kemenes T.: Nuclease-hypersensitive sites in the chromatin domain of the chicken lysozyme gene. Nucl. Acids Res. 11 (1983) 3467-3485.
129. Jantzen C., Fritton H. P., Igo-Kemenes T., Espel E., Janich S., Cato A. C. B., Mugele K. and Beato M.: Partial overlapping of binding sequences for steroid hormone receptors and DNaseI hypersensitive sites in the rabbit uteroglobin gene region. Nucleic. Acid Res. 15 (1987) 4535-4552.
130. Elgin S. C. R.: The formation and function of DNaseI hypersensitive sites in the process of gene activation. J. Biol. Chem. 263 (1988) 19,259-19,262.
131. Weih F., Nitsch D., Reik A., Schütz G. and Becker P. B.: Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo. EMBO J. 10 (1991) 2559-2567.
132. Reik A., Schütz G. and Stewart A. F.: Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: induction leads to a reversible disruption of nucleosomes over an enhancer. EMBO J. 10 (1991) 2569-2576.
133. Carr K. D. and Richard-Foy H.: Glucocorticoids locally disrupt and array of positioned nucleosomes on the rat amino transferase promoter in hepatoma cells. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 9300-9304.
134. Hebbes T. R., Thorne A. W. and Crane-Robinson C.: A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7 (1988) 1395-1402.
135. Bresnick E. H., John S., Berard D. S., LeFebvre P. and Hager G. L.: Glucocorticoid receptor-dependent disruption of a specific nucleosome on the mouse mammary tumor virus promoter is prevented by sodium butyrate. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 3977-3981.
136. Yoshida M., Kijima M., Akita M. and Beppu T.: Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265 (1990) 17,174-17,179.
137. Vettese-Dadey M., Walter P., Chen H., Juan L.-J. and Workman J. L.: Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nucleosomal cores. Molec. Cell. Biol. 14 (1994) 970-981.
138. Juan L.-J., Utley R. T., Adams C. C., Vettese-Dadey M. and Workman J. L.: Differential repression of transcription factor binding by histone H1 is regulated by the core histone amino termini. EMBO J. 13 (1994) 6031-6040.
139. Lee D. Y., Hayes J. J., Pruss D. and Wolffe A. P.: A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72 (1993) 73-84.
140. Hayes J. J. and Wolffe A. P.: Histones H2A/H2B inhibit the interaction of transcription factor-IIIA with the Xenopus borealis somatic 5S RNA gene in a nucleosome. Proc. Natn. Acad. Sci. U.S.A. 89 (1992) 1229-1233.
141. Peterson C. L. and Herskowitz I.: Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription. Cell 68 (1992) 573-583.
142. Cairns L. A., Crotta S., Minuzzo M., Moroni E., Granucci F., Nicolis S., Schiró R., Pozzi L., Giglioni B., Ricciardi-Castagnoli P. and Ottolenghi S.: Immortalization of multipotent growth-factor dependent hemopoietic progenitors from mice transgenic for GATA-1 driven SV40 tsA58 gene. EMBO J. 13 (1994) 4577-4586.
143. Peterson C. L., Dingwall A. and Scott M. P.: Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 2905-2908.
144. Côte J., Quinn J., Workmann J. L. and Peterson C. L.: Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science 265 (1994) 53-59.